Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTS-21 in Probable Alzheimer's Disease
NCT00414622Phase 2Completed
- Sponsor
- CoMentis, Inc.
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dmxb-a in Alzheimer's disease (AD), sponsored by CoMentis, Inc.. Started Nov 2006; status: completed.
02
Drugs
dmxb-a
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00414622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414622.